'One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial'

Huang, Hung-LingHung-LingHuangMENG-RUI LEELee, Chih-HsinChih-HsinLeeJANN-YUAN WANG2024-11-272024-11-272024-11https://scholars.lib.ntu.edu.tw/handle/123456789/723309en'One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial' - author's response.letter10.1016/j.cmi.2024.08.00939173876